Fund manager with 20% gain this year sees good times ahead as FDA becomes ‘more accommodating’ By: MarketWatch July 13, 2017 at 05:04 AM EDT Ziad Bakri, manager of the T. Rowe Price Health Sciences Fund, looks for three main themes in his stock picks. Read More >> Related Stocks: Agilent Technologies Alexion Pharmaceuticals Allergan Plc Becton Dickinson Cigna Corp Gilead Sciences Humana Incyte Corp Intuitive Surgical Regeneron Pharmaceuticals UnitedHealth Group Vertex Pharmaceuticals